Medos International Sarl

Clinical trials sponsored by Medos International Sarl, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Medical device subsidiary of Johnson & Johnson, focusing on neurosurgical products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Not yet finished but already full! 1 Completed 1

New stent shows promise for blocked brain arteries

Disease control Completed

This study tested a special stent designed to open severely narrowed brain arteries in 194 people with symptomatic intracranial atherosclerosis. The goal was to see if the stent is safe and effective at keeping arteries open for at least 12 months. Researchers measured how often …

Sponsor: Medos International SARL • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

Medos International Sarl

New stent shows promise for blocked brain arteries